PulseAugur
EN
LIVE 14:39:42
日本語(JA) https://www. wacoca.com/health/7144/ エクサウィザーズ、2026年度内の認知症AI診断アプリ承認へ PMDA相談を開始 – VOIX biz # AI # Alzheimer 'sDisease # DX # アルツハイマー病 # 規制・認証

Exawizards Inc. seeks AI dementia app approval by FY2026

Exawizards Inc. is aiming to receive approval for its AI-powered dementia diagnostic application by the end of fiscal year 2026. The company has initiated consultations with the Pharmaceuticals and Medical Devices Agency (PMDA) regarding the app's development and regulatory pathway. This initiative represents a significant step towards leveraging AI in the early detection and management of Alzheimer's disease. AI

IMPACT This AI application could accelerate dementia diagnosis and improve patient outcomes.

RANK_REASON Company seeking regulatory approval for an AI application.

Read on Mastodon — mastodon.social →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Exawizards Inc. seeks AI dementia app approval by FY2026

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
Company seeking regulatory approval for an AI application.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, policy
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
49 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Mastodon — mastodon.social TIER_1 日本語(JA) · [email protected] ·

    ExaWizards to Obtain Dementia AI Diagnostic App Approval within FY2026, Begins Consultation with PMDA – VOIX biz # AI # Alzheimer'sDisease # DX # アルツハイマー病 # 規制・認証

    https://www. wacoca.com/health/7144/ エクサウィザーズ、2026年度内の認知症AI診断アプリ承認へ PMDA相談を開始 – VOIX biz # AI # Alzheimer 'sDisease # DX # アルツハイマー病 # 規制・認証